Detalhe da pesquisa
1.
Meeting report: FDA public meeting on patient-focused drug development and medication adherence in solid organ transplant patients.
Am J Transplant
; 18(3): 564-573, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29288623
2.
Clarifications regarding the authority and role of FDA in drug approval.
Am J Transplant
; 20(4): 1210-1211, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31811778
3.
Qualification of biomarkers for drug development in organ transplantation.
Am J Transplant
; 8(2): 267-70, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18093264
4.
Summary of 2017 FDA Public Workshop: Antibody-mediated Rejection in Kidney Transplantation.
Transplantation
; 102(6): e257-e264, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29470345
5.
Biomarkers and surrogate endpoints in renal transplantation: present status and considerations for clinical trial design.
Am J Transplant
; 4(4): 451-7, 2004 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15023136